A detailed history of Kidder Stephen W transactions in Novartis Ag stock. As of the latest transaction made, Kidder Stephen W holds 12,409 shares of NVS stock, worth $1.34 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
12,409
Previous 20,256 38.74%
Holding current value
$1.34 Million
Previous $2.05 Million 41.32%
% of portfolio
0.39%
Previous 0.66%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$95.27 - $108.47 $747,583 - $851,164
-7,847 Reduced 38.74%
12,409 $1.2 Million
Q4 2023

Feb 13, 2024

SELL
$92.27 - $101.54 $702,082 - $772,617
-7,609 Reduced 27.31%
20,256 $2.05 Million
Q3 2023

Nov 14, 2023

SELL
$94.73 - $105.13 $20,840 - $23,128
-220 Reduced 0.78%
27,865 $2.84 Million
Q2 2023

Aug 11, 2023

BUY
$92.52 - $104.91 $8,326 - $9,441
90 Added 0.32%
28,085 $2.83 Million
Q1 2023

May 10, 2023

SELL
$80.03 - $92.81 $88,033 - $102,091
-1,100 Reduced 3.78%
27,995 $2.58 Million
Q4 2022

Feb 09, 2023

SELL
$75.55 - $92.52 $755 - $925
-10 Reduced 0.03%
29,095 $2.64 Million
Q3 2022

Nov 08, 2022

SELL
$74.61 - $87.26 $162,276 - $189,790
-2,175 Reduced 6.95%
29,105 $2.21 Million
Q2 2022

Jul 19, 2022

SELL
$80.52 - $93.75 $717,594 - $835,500
-8,912 Reduced 22.17%
31,280 $2.64 Million
Q1 2022

May 17, 2022

SELL
$80.11 - $90.62 $204,520 - $231,352
-2,553 Reduced 5.97%
40,192 $3.53 Million
Q4 2021

Feb 08, 2022

SELL
$79.7 - $88.13 $1.11 Million - $1.23 Million
-13,923 Reduced 24.57%
42,745 $3.74 Million
Q3 2021

Nov 10, 2021

SELL
$81.78 - $95.14 $534,595 - $621,930
-6,537 Reduced 10.34%
56,668 $4.63 Million
Q2 2021

Aug 09, 2021

SELL
$85.24 - $94.15 $561,390 - $620,071
-6,586 Reduced 9.44%
63,205 $5.77 Million
Q1 2021

May 17, 2021

SELL
$83.5 - $98.47 $382,430 - $450,992
-4,580 Reduced 6.16%
69,791 $5.97 Million
Q4 2020

Feb 16, 2021

SELL
$78.07 - $94.43 $121,008 - $146,366
-1,550 Reduced 2.04%
74,371 $7.02 Million
Q3 2020

Oct 28, 2020

SELL
$82.14 - $91.0 $29,570 - $32,760
-360 Reduced 0.47%
75,921 $6.6 Million
Q2 2020

Jul 28, 2020

BUY
$80.93 - $91.1 $7,688 - $8,654
95 Added 0.12%
76,281 $6.66 Million
Q1 2020

May 07, 2020

SELL
$70.67 - $99.01 $64,097 - $89,802
-907 Reduced 1.18%
76,186 $6.28 Million
Q4 2019

Jan 15, 2020

SELL
$84.35 - $95.37 $133,104 - $150,493
-1,578 Reduced 2.01%
77,093 $7.3 Million
Q3 2019

Nov 07, 2019

BUY
$85.54 - $94.26 $149,267 - $164,483
1,745 Added 2.27%
78,671 $6.84 Million
Q2 2019

Jul 24, 2019

SELL
$75.4 - $92.8 $86,860 - $106,905
-1,152 Reduced 1.48%
76,926 $7.02 Million
Q1 2019

May 01, 2019

SELL
$75.32 - $86.15 $498,618 - $570,313
-6,620 Reduced 7.82%
78,078 $7.51 Million
Q4 2018

Jan 24, 2019

SELL
$73.66 - $82.02 $129,346 - $144,027
-1,756 Reduced 2.03%
84,698 $7.27 Million
Q3 2018

Oct 15, 2018

SELL
$66.94 - $77.43 $100,410 - $116,145
-1,500 Reduced 1.71%
86,454 $7.45 Million
Q2 2018

Jul 30, 2018

BUY
$64.91 - $73.36 $70,102 - $79,228
1,080 Added 1.24%
87,954 $6.64 Million
Q1 2018

Apr 24, 2018

SELL
$70.39 - $84.15 $226,866 - $271,215
-3,223 Reduced 3.58%
86,874 $7.02 Million
Q4 2017

Feb 02, 2018

BUY
$72.33 - $77.64 $57,068 - $61,257
789 Added 0.88%
90,097 $7.57 Million
Q3 2017

Oct 26, 2017

BUY
$74.14 - $77.27 $6.62 Million - $6.9 Million
89,308
89,308 $7.67 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $233B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Kidder Stephen W Portfolio

Follow Kidder Stephen W and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kidder Stephen W, based on Form 13F filings with the SEC.

News

Stay updated on Kidder Stephen W with notifications on news.